Opioids and Heroin: A New Look at Some Old (and Not So Old) Drugs

CMEO Webcast

Live Webcast: Tuesday, September 18, 2018
1:00 PM – 2:30 PM ET

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Wednesday, September 18, 2019

Faculty

Mark S. Gold, MD Mark S. Gold, MD (Moderator)
ASAM’s Annual Lifetime Achievement John P. McGovern Award & Prize winner
Adjunct Professor of Psychiatry
Washington University School of Medicine
St. Louis, MO
17th University of Florida Distinguished Alumni Professor
Gainesville, FL
Dolores Breiner Dolores Breiner
Intelligence Research Specialist
Domestic Strategic Intelligence Unit, DEA
Arlington, VA
Brian Fuehrlein, MD, PhD Brian Fuehrlein, MD, PhD
Assistant Professor of Psychiatry
Yale University School of Medicine
Director, Psychiatric Emergency Room
VA Connecticut Healthcare System
New Haven, CT
Bruce A. Goldberger, PhD Bruce A. Goldberger, PhD
Chief, Director and Professor
Department of Pathology, Immunology and Laboratory Medicine
University of Florida College of Medicine
Gainesville, FL
Teresa A. Rummans, MD Teresa A. Rummans, MD
Donald and Lucy Dayton Professor of Psychiatry
Mayo Clinic
Rochester, MN
Jacksonville, FL

Statement of Need

Drug overdoses are now the leading cause of injury-related death in the United States, eclipsing deaths from motor vehicle crashes or firearms. According to the Centers for Disease Control and Prevention (CDC), there were nearly 64,000 overdose deaths in 2016, or approximately 174 per day. Over 42,249 (66 percent) of these deaths involved opioids. CDC’s preliminary data estimates more than 74,000 drug overdose deaths in 2017.

The U.S. opioid overdose epidemic is still worsening; emergency department visits for suspected opioid overdoses increased 30% in 45 states between July 2016 and September 2017, and all five U.S. regions experienced rate increases.

The increase in the number of people using heroin in recent years – from 373,000 past year users in 2007 to 948,000 in 2016 – is troubling. More alarming is the proliferation of illicit fentanyl and its analogues. DEA investigations reveal that illicit fentanyl and its analogues are increasingly being added to heroin and frequently pressed into counterfeit tablets resembling CPDs. Overdose deaths involving heroin are increasing at an alarming rate, having increased more than five-fold since 2010.

Experts in the opioid epidemic and the heroin threat will discuss the crisis of opioid addiction and overdose in this webinar.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Review the history and origins of the opioid crisis.
  • Discuss the role of fentanyl in opioid overdoses and deaths.
  • Examine the use of medication assisted treatment for opioid disorder in an emergency room setting.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Review the history and origins of the opioid crisis.
  • Discuss the role of fentanyl in opioid overdoses and deaths.
  • Summarize the use of medication assisted treatment for opioid use disorder in an emergency room setting.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses and pharmacists.

Credit Information

CME Credit (Physicians):
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC and The Drug Enforcement Administration. CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live actvity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners:Nurse practitioners can apply for AMA PRA Category 1 Credit™through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credits™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number: 0376-0000-18-024-L01-P

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST28433 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Gold has no disclosures to report.

Ms. Breiner has no disclosures to report.

Dr. Goldberger has no disclosures to report.

Dr. Fuehrlein has no disclosures to report.

Dr. Rummans has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures have been obtained from CME Outfitters staff: No disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.